Leo Heyndríckx

2.5k total citations
63 papers, 1.5k citations indexed

About

Leo Heyndríckx is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Leo Heyndríckx has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Virology, 41 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Leo Heyndríckx's work include HIV Research and Treatment (49 papers), HIV/AIDS drug development and treatment (24 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Leo Heyndríckx is often cited by papers focused on HIV Research and Treatment (49 papers), HIV/AIDS drug development and treatment (24 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Leo Heyndríckx collaborates with scholars based in Belgium, United States and United Kingdom. Leo Heyndríckx's co-authors include Wouter Janssens, Guido van der Groen, Katrien Fransen, Peter Piot, John N. Nkengasong, Katleen Vereecken, J. Motte, Johan Míchiels, Guido Vanham and Betty Willems and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Leo Heyndríckx

61 papers receiving 1.5k citations

Peers

Countries citing papers authored by Leo Heyndríckx

Since Specialization

Citations

This map shows the geographic impact of Leo Heyndríckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Heyndríckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Heyndríckx more than expected).

Fields of papers citing papers by Leo Heyndríckx

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Heyndríckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Heyndríckx. The network helps show where Leo Heyndríckx may publish in the future.

Co-authorship network of co-authors of Leo Heyndríckx

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Heyndríckx. A scholar is included among the top collaborators of Leo Heyndríckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Heyndríckx. Leo Heyndríckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients 2024 ·The Journal of Heart and Lung Transplantation ·Isabelle Étienne, Delphine Kemlin, (unknown), Véronique Olislagers, (unknown), (unknown), Leo Heyndríckx, Stéphanie Depickère, Alexia Charles, (unknown), Leen Vandermosten, Isabelle Desombere, Kevin K. Ariën, Pieter Pannus, Christiane Knoop, Arnaud Marchant	1
2	Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients 2023 ·American Journal of Transplantation ·Delphine Kemlin, (unknown), Stéphanie Depickère, Véronique Olislagers, (unknown), (unknown), Pieter Pannus, Anne Lemy, Maria E. Goossens, Isabelle Desombere, Johan Míchiels, Marylène Vandevenne, Leo Heyndríckx, Kevin K. Ariën, André Matagne, Margaret E. Ackerman, Alaín Le Moine, Arnaud Marchant	15
3	SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations 2023 ·Nature Communications ·(unknown), Harini Natarajan, Leo Heyndríckx, Kevin K. Ariën, (unknown), Peter F. Wright, Evan M. Bloch, Aaron A.R. Tobian, Andrew D. Redd, Joel N. Blankson, Amihai Rottenstreich, (unknown), Dana G. Wolf, Tessa Goetghebuer, Arnaud Marchant, Margaret E. Ackerman	4
4	A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity 2022 ·Molecular Therapy ·Séan Mc Cafferty, A.K.M. Ashiqul Haque, (unknown), (unknown), (unknown), (unknown), Nathalie R. Le François, (unknown), Leo Heyndríckx, Johan Míchiels, Kevin K. Ariën, Linos Vandekerckhove, Rana Abdelnabi, Caroline S. Foo, Johan Neyts, Itishri Sahu, Niek N. Sanders	40
5	SARS‐CoV‐2 surveillance in Norway rats ( Rattus norvegicus ) from Antwerp sewer system, Belgium 2021 ·Transboundary and Emerging Diseases ·Valeria Colombo, Vincent Sluydts, Joachim Mariën, Bram Vanden Broecke, Natalie Van Houtte, (unknown), (unknown), Arne Iserbyt, (unknown), Leo Heyndríckx, (unknown), Peter Delputte, Naomi De Roeck, (unknown), Kevin K. Ariën, Herwig Leirs, Sophie Gryseels	25
6	Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study 2021 ·BMJ Open ·(unknown), Kristien Verdonck, Veronik Hutse, Isabelle Thomas, Cyril Barbezange, Leo Heyndríckx, Natalie Fischer, Béa Vuylsteke, (unknown), Kevin K. Ariën, Isabelle Desombere, Els Duysburgh	19
7	Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2 2021 ·Journal of Virological Methods ·Joachim Mariën, Johan Míchiels, Leo Heyndríckx, Antoine Nkuba-Ndaye, (unknown), Koen Bartholomeeusen, Joule Madinga, Placide Mbala‐Kingebeni, Veerle Vanlerberghe, Steve Ahuka‐Mundeke, Lin‐Fa Wang, Kevin K. Ariën	28
8	Monocytes Contribute to Differential Immune Pressure on R5 versus X4 HIV through the Adipocytokine Visfatin/NAMPT 2012 ·PLoS ONE ·Rafaël Van den Bergh, Sébastien Morin, Hans Jürgen Sass, Stephan Grzesiek, Marc Vekemans, Éric Florence, (unknown), (unknown), Leo Heyndríckx, Guido Vanham, Patrick De Baetselier, Geert Raes	34
9	Longitudinal Study of Primary HIV-1 Isolates in Drug-Naïve Individuals Reveals the Emergence of Variants Sensitive to Anti-HIV-1 Monoclonal Antibodies 2011 ·PLoS ONE ·(unknown), Sherri Burda, Constance Williams, Leo Heyndríckx, Guido Vanham, Miroslaw K. Górny, Phillipe N. Nyambi	4
10	Neutralization Patterns and Evolution of Sequential HIV Type 1 Envelope Sequences in HIV Type 1 Subtype B-Infected Drug-Naive Individuals 2008 ·AIDS Research and Human Retroviruses ·Phillipe N. Nyambi, Sherri Burda, Mateusz M. Urbanski, Leo Heyndríckx, Wouter Janssens, Guido Vanham, Arthur Nádas	5
11	CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides 2008 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), (unknown), Liesbeth Aerts, Johan Míchiels, Leo Heyndríckx, Loı̈c Martin, Guido Vanham	49
12	The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection 2007 ·Journal of Immunological Methods ·Sophia Steyaert, Lieven Verhoye, Els Beirnaert, (unknown), Katrien Fransen, Leo Heyndríckx, Guido Vanham, Geert Leroux‐Roels, Peter Vanlandschoot	2
13	Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity 2005 ·Virology ·Fatim Cham, Pengfei Zhang, Leo Heyndríckx, Peter Bouma, Ping Zhong, (unknown), James E. Robinson, Guido van der Groen, Gerald V. Quinnan	20
14	Near Full-Length Genome Analysis of HIV Type 1 CRF02.AG, Subtype C and CRF02.AG Subtype G Recombinants 2000 ·AIDS Research and Human Retroviruses ·Wouter Janssens, Mika Salminen, Tiina Laukkanen, Leo Heyndríckx, Gert Van der Auwera, Robert Colebunders, Francine E. McCutchan, Guido van der Groen	17
15	The Neutralization Relationship of HIV Type 1, HIV Type 2, and SIVcpz Is Reflected in the Genetic Diversity that Distinguishes Them 1997 ·AIDS Research and Human Retroviruses ·Phillipe N. Nyambi, Betty Willems, Wouter Janssens, Katrien Fransen, John N. Nkengasong, Martine Peeters, Katleen Vereecken, Leo Heyndríckx, Peter Piot, Guido van der Groen	16
16	Genetic and Antigenic Variability of HIV Type 1 in Brazil 1994 ·AIDS Research and Human Retroviruses ·José Carlos Couto-Fernandez, Wouter Janssens, Leo Heyndríckx, J. Motte, Katrien Fransen, Martine Peeters, Éric Delaporte, (unknown), Peter Piot, Guido van der Groen	18
17	Isolation of Simian Immunodeficiency Viruses from Two Sooty Mangabeys in Côte d'Ivoire: Virological and Genetic Characterization and Relationship to Other HIV Type 2 and SIVsm/mac Strains 1994 ·AIDS Research and Human Retroviruses ·(unknown), Wouter Janssens, Katrien Fransen, J. A. M. Brandful, Leo Heyndríckx, (unknown), Éric Delaporte, Peter Piot, (unknown), Guido van der Groen	42
18	Phylogenetic Analysis of a New Chimpanzee Lentivirus SIV _cpz-gab2 from a Wild-Captured Chimpanzee from Gabon 1994 ·AIDS Research and Human Retroviruses ·Wouter Janssens, Katrien Fransen, Marc Peeters, Leo Heyndríckx, J. Motte, Léonard Bedjabaga, Éric Delaporte, Peter Piot, Guido van der Groen	36
19	Genetic and Phylogenetic Analysis of env Subtypes G and H in Central Africa 1994 ·AIDS Research and Human Retroviruses ·Wouter Janssens, Leo Heyndríckx, Karin Fransén, J. Motte, Marc Peeters, John N. Nkengasong, Peter M. Ndumbe, Éric Delaporte, J L Perret, (unknown), Peter Piot, Guido van der Groen	87
20	Genetic Variability of HIV Type 1 in Kenya 1994 ·AIDS Research and Human Retroviruses ·Wouter Janssens, Leo Heyndríckx, Karin Fransén, M Temmerman, (unknown), Tania Ivens, J. Motte, Peter Piot, Guido van der Groen	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact